Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections
Status:
Completed
Trial end date:
2017-05-19
Target enrollment:
Participant gender:
Summary
This is a Phase 3, randomized, double-blind, double-dummy, multicenter, prospective study to
assess the efficacy, safety, and pharmacokinetics (PK) of eravacycline compared with
meropenem in the treatment of complicated intra-abdominal infections (cIAIs).